OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (14)

  1. Fabiola Atzeni, Valeria Nucera, Elisabetta Gerratana, Mariateresa Cirillo, Francesca Marino, Gianfranco Miceli, Donatella Sangari, Laura Boccassini, Ignazio Francesco Masala. Concerns about the safety of anti-TNF agents when treating rheumatic diseases. Expert Opinion on Drug Safety 2020;19:695
    https://doi.org/10.1080/14740338.2020.1763299
  2. Chinar R. Parikh, Jaya K. Ponnampalam, George Seligmann, Leda Coelewij, Ines Pineda-Torra, Elizabeth C. Jury, Coziana Ciurtin. Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults. Therapeutic Advances in Musculoskeletal 2021;13:1759720X2110026
    https://doi.org/10.1177/1759720X211002685
  3. Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni, Edoardo Spina. Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. JCM 2020;9:1227
    https://doi.org/10.3390/jcm9041227
  4. Vibeke Strand, Joao Goncalves, John D. Isaacs. Immunogenicity of biologic agents in rheumatology. Nat Rev Rheumatol 2021;17:81
    https://doi.org/10.1038/s41584-020-00540-8
  5. Jean-Guillaume Letarouilly, Jean-Hugues Salmon, René-Marc Flipo. Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review. Expert Opinion on Drug Safety 2021;20:1087
    https://doi.org/10.1080/14740338.2021.1924146
  6. Sarfaraz K. Niazi, Waleed Mohammed Al-Shaqha, Zafar Mirza. Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars. Journal of Market Access & Health Policy 2023;11
    https://doi.org/10.1080/20016689.2022.2147286
  7. Oscar Pizano-Martinez, Edgar Mendieta-Condado, Mónica Vázquez-Del Mercado, Erika Aurora Martínez-García, Efrain Chavarria-Avila, Daniel Ortuño-Sahagún, Ana Laura Márquez-Aguirre. Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases. JCM 2023;12:3271
    https://doi.org/10.3390/jcm12093271
  8. Soo-Youn Lee. Therapeutic Drug Monitoring of Biologic Agents in the Era of Precision Medicine. Ann Lab Med 2020;40:95
    https://doi.org/10.3343/alm.2020.40.2.95
  9. Askin Gülsen, Bettina Wedi, Uta Jappe. Hypersensitivity reactions to biologics (part II): classifications and current diagnostic and treatment approaches*. Allergo J 2020;29:25
    https://doi.org/10.1007/s15007-020-2567-5
  10. Roberto Verna. From alchemy to personalised medicine: the journey of laboratory medicine. J Clin Pathol 2023;76:301
    https://doi.org/10.1136/jcp-2022-208492
  11. Marino Paroli, Andrea Becciolini, Elena Bravi, Romina Andracco, Valeria Nucera, Simone Parisi, Francesca Ometto, Federica Lumetti, Antonella Farina, Patrizia Del Medico, Matteo Colina, Alberto Lo Gullo, Viviana Ravagnani, Palma Scolieri, Maddalena Larosa, Marta Priora, Elisa Visalli, Olga Addimanda, Rosetta Vitetta, Alessandro Volpe, Alessandra Bezzi, Francesco Girelli, Aldo Biagio Molica Colella, Rosalba Caccavale, Eleonora Di Donato, Giuditta Adorni, Daniele Santilli, Gianluca Lucchini, Eugenio Arrigoni, Ilaria Platè, Natalia Mansueto, Aurora Ianniello, Enrico Fusaro, Maria Chiara Ditto, Vincenzo Bruzzese, Dario Camellino, Gerolamo Bianchi, Francesca Serale, Rosario Foti, Giorgio Amato, Francesco De Lucia, Ylenia Dal Bosco, Roberta Foti, Massimo Reta, Alessia Fiorenza, Guido Rovera, Antonio Marchetta, Maria Cristina Focherini, Fabio Mascella, Simone Bernardi, Gilda Sandri, Dilia Giuggioli, Carlo Salvarani, Veronica Franchina, Francesco Molica Colella, Giulio Ferrero, Alarico Ariani. Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study. Medicina 2023;59:1480
    https://doi.org/10.3390/medicina59081480
  12. Reem Kashlan, Alexis B. Lyons, Shanthi Narla, Iltefat H. Hamzavi. Infusion reaction to infliximab biosimilar after transitioning from infliximab. JAAD Case Reports 2021;8:77
    https://doi.org/10.1016/j.jdcr.2020.12.011
  13. Konstantinos Papamichael, Waqqas Afif, David Drobne, Marla C Dubinsky, Marc Ferrante, Peter M Irving, Nikolaos Kamperidis, Taku Kobayashi, Paulo G Kotze, Jo Lambert, Nurulamin M Noor, Xavier Roblin, Giulia Roda, Niels Vande Casteele, Andres J Yarur, Naila Arebi, Silvio Danese, Stephane Paul, William J Sandborn, Séverine Vermeire, Adam S Cheifetz, Laurent Peyrin-Biroulet. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. The Lancet Gastroenterology & Hepatology 2022;7:171
    https://doi.org/10.1016/S2468-1253(21)00223-5
  14. Askin Gülsen, Bettina Wedi, Uta Jappe. Hypersensitivity reactions to biologics (part II): classifications and current diagnostic and treatment approaches. Allergo J Int 2020;29:139
    https://doi.org/10.1007/s40629-020-00127-5